188 related articles for article (PubMed ID: 37563118)
1. Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma.
Liu L; Deng P; Liu S; Hong JH; Xiao R; Guan P; Wang Y; Wang P; Gao J; Chen J; Sun Y; Chen J; Mai HQ; Tan J
Cell Death Dis; 2023 Aug; 14(8):513. PubMed ID: 37563118
[TBL] [Abstract][Full Text] [Related]
2. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.
Zhu Y; Hu Q; Li H
Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403
[TBL] [Abstract][Full Text] [Related]
3. The m6A reader IGF2BP3 preserves NOTCH3 mRNA stability to sustain Notch3 signaling and promote tumor metastasis in nasopharyngeal carcinoma.
Chen B; Huang R; Xia T; Wang C; Xiao X; Lu S; Chen X; Ouyang Y; Deng X; Miao J; Zhao C; Wang L
Oncogene; 2023 Nov; 42(48):3564-3574. PubMed ID: 37853162
[TBL] [Abstract][Full Text] [Related]
4. CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization.
Hong X; Li Q; Li J; Chen K; He Q; Zhao Y; Liang Y; Zhao Y; Qiao H; Liu N; Ma J; Li Y
Clin Cancer Res; 2022 Oct; 28(20):4521-4535. PubMed ID: 35917517
[TBL] [Abstract][Full Text] [Related]
5. LINC00210 as a miR-328-5p sponge promotes nasopharyngeal carcinoma tumorigenesis by activating NOTCH3 pathway.
Zhang S; Li P; Zhao L; Xu L
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341249
[TBL] [Abstract][Full Text] [Related]
6. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
Zhao Y; Wang P; Wu Q
Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
[TBL] [Abstract][Full Text] [Related]
7. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
8. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
9.
Li Y; Yang X; Du X; Lei Y; He Q; Hong X; Tang X; Wen X; Zhang P; Sun Y; Zhang J; Wang Y; Ma J; Liu N
Clin Cancer Res; 2018 Dec; 24(24):6495-6508. PubMed ID: 30131385
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma.
Man CH; Wei-Man Lun S; Wai-Ying Hui J; To KF; Choy KW; Wing-Hung Chan A; Chow C; Tin-Yun Chung G; Tsao SW; Tak-Chun Yip T; Busson P; Lo KW
J Pathol; 2012 Feb; 226(3):471-81. PubMed ID: 22009689
[TBL] [Abstract][Full Text] [Related]
11. The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway.
Zhu Y; He D; Bo H; Liu Z; Xiao M; Xiang L; Zhou J; Liu Y; Liu X; Gong L; Ma Y; Zhou Y; Zhou M; Xiong W; Yang F; Xing X; Li R; Li W; Cao K
Oncogene; 2019 Aug; 38(32):6065-6081. PubMed ID: 31273338
[TBL] [Abstract][Full Text] [Related]
12. miR-491-5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma.
Zhang Q; Li Q; Xu T; Jiang H; Xu LG
Oncol Rep; 2016 Jun; 35(6):3541-7. PubMed ID: 27035429
[TBL] [Abstract][Full Text] [Related]
13. ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.
Cai J; Chen S; Yi M; Tan Y; Peng Q; Ban Y; Yang J; Li X; Zeng Z; Xiong W; McCarthy JB; Li G; Li X; Xiang B
Carcinogenesis; 2020 Sep; 41(9):1282-1293. PubMed ID: 31826234
[TBL] [Abstract][Full Text] [Related]
14. Integrin α5 mediates intrinsic cisplatin resistance in three-dimensional nasopharyngeal carcinoma spheroids via the inhibition of phosphorylated ERK /caspase-3 induced apoptosis.
Ngaokrajang U; Janvilisri T; Sae-Ueng U; Prungsak A; Kiatwuthinon P
Exp Cell Res; 2021 Sep; 406(2):112765. PubMed ID: 34358523
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW
BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1.
Hong X; Liu N; Liang Y; He Q; Yang X; Lei Y; Zhang P; Zhao Y; He S; Wang Y; Li J; Li Q; Ma J; Li Y
Mol Cancer; 2020 Feb; 19(1):33. PubMed ID: 32061262
[TBL] [Abstract][Full Text] [Related]
17. Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway.
Zhang J; Xie T; Zhong X; Jiang HL; Li R; Wang BY; Huang XT; Cen BH; Yuan YW
Aging (Albany NY); 2020 Mar; 12(6):5423-5438. PubMed ID: 32203052
[TBL] [Abstract][Full Text] [Related]
18. PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma.
Huang SY; Gong S; Zhao Y; Ye ML; Li JY; He QM; Qiao H; Tan XR; Wang JY; Liang YL; Huang SW; He SW; Li YQ; Xu S; Li YQ; Liu N
Nat Commun; 2024 Jun; 15(1):5300. PubMed ID: 38906860
[TBL] [Abstract][Full Text] [Related]
19. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
[TBL] [Abstract][Full Text] [Related]
20. Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p.
Wang X; Wang K; Xiao J; Song Y; Li H
Biochem Biophys Res Commun; 2020 Oct; 531(4):573-580. PubMed ID: 32811645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
